"Ivermectin is the Biggest Threat to the Vaccine Industry, "Dr. Paul Marik tells Emerald Robinson. Doctors need to speak out about what is happening in the world and why they are legitimately afraid to do so.
This helpful infographic compares newly approved antiviral Paxlovid to ivermectin in regard to treating COVID-19.
This helpful infographic compares intensive care approved Remdesivir to ivermectin in regard to treating COVID-19.
In this week’s FLCCC Weekly Update Dr. Pierre Kory and Dr. Flavio Cadegiani walk the audience through the TOGETHER trial, which was recently released and made headlines around the world regarding the effectiveness of ivermectin.
The Forces Against ivermectin features Phil Harper, documentary producer and author of The Digger substack, discussing Andrew Hill’s paper on the efficacy of ivermectin.
Authors: Hazan S, Dave S, Gunaratne AW, Dolai S, Clancy RL, McCullough PA et al. PMID: 35135310 PMCID: PMC8826831 DOI: 10.2217/fmb-2022-0014 Abstract Aims: Ivermectin is a safe, inexpensive and effective early COVID-19 treatment validated in 20+ random, controlled trials. Having developed combination therapies for Helicobacter pylori, the authors present a highly effective COVID-19 therapeutic [...]
Authors: Jeffreys L, Pennington SH, Duggan J, Breen A, Jinks J PMID: 35093538 PMCID: PMC8801767 DOI: 10.1016/j.ijantimicag.2022.106542 Abstract A key element for the prevention and management of coronavirus disease 2019 is the development of effective therapeutics. Drug combination strategies offer several advantages over monotherapies. They have the potential to achieve greater efficacy, to increase the [...]
Regular use of ivermectin as a prophylactic was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates. The results are in from the world’s largest study of ivermectin for COVID-19.
Writing in The New American, Selwyn Duke says many people find it shocking to learn that two years into the pandemic there are still no official treatment protocols for COVID-19.


